Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
98 participants
OBSERVATIONAL
2016-02-29
2020-03-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The way alcohol affects brain structure has been widely studied. But the way it affects all parts of the brain is still unknown. Researchers want to use magnetic resonance imaging (MRI) scans to study brain structure and function. They hope this will help them better understand changes that happen in brain regions during treatment of alcohol use disorders.
Objectives:
To study changes in the brain by using MRI in people with and without alcohol use disorders. To study how brain changes affect gait, balance, cognitive ability, and behavior. To see how the brain recovers when alcohol use stops.
Eligibility:
People with alcohol dependence who are currently hospitalized in a particular unit at NIH.
Healthy volunteers 30 60 years old without an alcohol use disorder.
Design:
Participants will be screened under a separate protocol.
Participants will give a urine sample for a drug test and pregnancy test at each study visit. They will also have to pass a breath alcohol test.
At the first visit, participants will have an MRI. The scanner is a metal cylinder in a strong magnetic field. Participants will lie on a table that slides in and out of the cylinder.
They will do behavior and memory tasks outside the scanner.
They will have gait and balance tested. They will have to stand on both legs, stand on just one leg, and walk in a straight line. They will perform each task with eyes open, then with eyes closed.
They will have tests of memory, thinking, and problem solving.
Some participants will have a second visit. They will have another MRI and repeat some of the behavior and memory tasks.
...
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
NCT01036581
Study of New Magnetic Resonance Imaging Methods of the Brain
NCT00004577
Evaluation of Age- and Alzheimer's Disease-Related Memory Disorder
NCT00029120
MRS Probe Study of Alcohol
NCT01679444
Imaging Blood Brain Imaging Dysfunction in Parkinson's Disease
NCT02605161
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The purpose of this protocol is to characterize cerebellar volumes and function in alcoholics and recovery of cerebellar volume and function during early abstinence. This study also investigates how cerebrocerebellar circuits contribute to cognitive and motor impairment in alcoholism.
Study Population
Healthy volunteers and Inpatient participants with alcohol use disorders.
Design
Participants will receive whole-brain structural imaging and assessment of cerebellar function at the time of admission and again at the time of discharge.
Outcome
The Primary outcome of this study is to assess recovery of cerebellar structure and function at the end of treatment compared to treatment entry measures.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy Controls
125 non-substance abusing controls (NSAC)
No interventions assigned to this group
Individuals with Alcohol Use Disorder
This group includes individuals who enrolled NIAAA alcohol treatment.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Physically healthy
3. Healthy volunteers only: Currently consuming 7 or less standard drinks per week if female; 14 or less drinks per week if male.
Exclusion Criteria
2. History of diabetes or stroke which requires medical intervention,
3. Clinical or laboratory evidence of severe hepatic disease as determined by ALT or AST greater than 5 times the upper normal limit, INR greater than 2.0, total bilirubin greater than 2.5 mg/dL, and albumin lower than 3.0 g/dL.
4. Positive HIV test.
5. Healthy volunteers only: 5 or more binge drinking episodes in the past 30 days (5 or more standard drinks on one occasion for males, 4 or more standard drinks on one occasion for females within two hours)
6. Healthy volunteers only:
--Have fulfilled DSM-IV or DSM-5 criteria for current alcohol use disorder or substance abuse disorder
7. Inpatient participants only: Currently experiencing symptoms of withdrawal from alcohol (As determined by the most recent measurement within the past 30 days CIWA score \> 8)
8. Female participants only: Are currently pregnant
9. IPresence of any contraindication for fMRI as determined by the NIAAA MRI Safety Screening Questionnaire
10. Have calustrophobia
30 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
NIH
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Reza Momenan, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Institutes of Health Clinical Center
Bethesda, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
NIH Clinical Center Detailed Web Page
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
15-AA-0203
Identifier Type: -
Identifier Source: secondary_id
150203
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.